Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

June 15, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2025

Conditions
Acute Lymphoblastic Leukemia
Trial Locations (1)

2100

RECRUITING

Kjeld Schmiegelow, Copenhagen

All Listed Sponsors
collaborator

Danish Child Cancer Foundation

OTHER

collaborator

Aarhus University Hospital

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Aalborg University Hospital

OTHER

collaborator

Royal Children's Hospital

OTHER

collaborator

St. Jude Children's Research Hospital

OTHER

collaborator

Princess Maxima Center for Pediatric Oncology

OTHER

collaborator

Nordic Society for Pediatric Hematology and Oncology

OTHER

collaborator

Medical University of Lodz

OTHER

lead

Rigshospitalet, Denmark

OTHER